Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Mogees is a London-based company with the objective to disrupt the relationship between people and physical objects. Their patent-pending technology allows anyone to transform ordinary physical objects into ‘smart’ ones through the power of machine learning and a vibration sensor.
days to go:
Expired
investment:
£1,153,867
Launched in 2017, Algarve Rock is on a mission to put Portuguese craft beer on the map with flavoursome beers that embody local ingredients. The global craft beer market is expected to reach nearly $187 billion by 2025. It has carved a niche for itself in only 18 months of its inception. The 3,000 litre Brew House associated fermentation vessels and auto bottling line allow them to produce 36,000 litres per month, readily expandable to 80,000 litres to meet growing demand. Algarve Rock was the winner of the Best Stout - Trujillo Festival 2018, Spain and is the house brewer for prestigious institutions like Quinta do Lago group and Casa do Frango restaurants in London. With the investment, the company will use 40% to open Algarve Rock-themed Brewbars and Brew kiosks, 10% in increasing exports especially to the UK and USA, 10% in strengthening brand identity, 15% in recruitment procedures, and 25% in increasing brewing capacity to cater to new markets.
days to go:
Expired
investment:
£281,607
Migrate is an automatic switching service designed for the customer's expenses by providing the cheapest energy deal per year. This new vertical has signed up 200,000+ people till date. Migrate's technology is the best in generating the largest savings of any of the free switching service. Migrate has recurrent annual revenues related to transactional-based price matching websites. Migrate aims to sell the business to an established trade buyer having achiever of 600,000+ users delivring recurring revenues.
days to go:
Expired
investment:
£610,006
Offering a more affordable fitness class solution through training small groups and providing unparalleled client care with 1-on-1 personal training sessions. Outrivals has grown rapidly since launching 3 years ago near the famous Old Street Roundabout and are raising funds to open 2 new sites, with plans to have a portfolio of 15 branches over the next 5 years. The company has a high retention rate, with a client life cycle averaging one year.
days to go:
Expired
investment:
£88,450
Doctaly is the brand new healthcare platform providing the quickest way to find and book an affordable, face-to-face, same day GP appointment. Choose from their trusted private doctors, at a convenient time and location from just £39.99.
days to go:
Expired
investment:
£807,580
